Imugene Correlations

IMU Stock   0.04  0  2.56%   
The current 90-days correlation between Imugene and Hutchison Telecommunications is -0.15 (i.e., Good diversification). The correlation of Imugene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
The ability to find closely correlated positions to Imugene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Imugene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Imugene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Imugene to buy it.

Moving against Imugene Stock

  0.82PNI Pinnacle InvestmentPairCorr
  0.78QAN Qantas AirwaysPairCorr
  0.74TLX Telix PharmaceuticalsPairCorr
  0.72SVW SEVEN GROUP HOLDINGSPairCorr
  0.7CBA Commonwealth BankPairCorr
  0.62VUL Vulcan Energy ResourcesPairCorr
  0.61AXP AXP Energy LimitedPairCorr
  0.53SXL Southern Cross MediaPairCorr
  0.53COH CochlearPairCorr
  0.39HMC Home ConsortiumPairCorr
  0.36MAQ Macquarie TechnologyPairCorr
  0.32CLE Cyclone Metals SplitPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HCWRHC
ABBRHC
TWERHC
ABBHCW
HCWTWE
ABBTWE
  
High negative correlations   
HCWAHC
RHCAHC
TWEAHC
HTAEVT
HCWEVT
ABBAHC

Risk-Adjusted Indicators

There is a big difference between Imugene Stock performing well and Imugene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Imugene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Imugene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Directory Now

   

Commodity Directory

Find actively traded commodities issued by global exchanges
All  Next Launch Module

Imugene Corporate Management

Elected by the shareholders, the Imugene's board of directors comprises two types of representatives: Imugene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imugene. The board's role is to monitor Imugene's management team and ensure that shareholders' interests are well served. Imugene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imugene's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD WoodardChief OfficerProfile
John ByonSenior DevelopmentProfile
Bradley GloverChief OfficerProfile
Nathan CAJoint SecProfile
PharmD MBAChief OfficerProfile
John MDSenior DevelopmentProfile